Yawei Liu

3.3k total citations
113 papers, 2.5k citations indexed

About

Yawei Liu is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Yawei Liu has authored 113 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 27 papers in Cancer Research and 21 papers in Genetics. Recurrent topics in Yawei Liu's work include Glioma Diagnosis and Treatment (20 papers), MicroRNA in disease regulation (12 papers) and Cancer-related molecular mechanisms research (11 papers). Yawei Liu is often cited by papers focused on Glioma Diagnosis and Treatment (20 papers), MicroRNA in disease regulation (12 papers) and Cancer-related molecular mechanisms research (11 papers). Yawei Liu collaborates with scholars based in China, United States and Ireland. Yawei Liu's co-authors include Songtao Qi, Xuegang Sun, Liang Zhao, Guozhong Yi, Minyi He, Linlin Jing, Jun Pan, Bingxi Lei, Hai Wang and Guanglong Huang and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and PLoS ONE.

In The Last Decade

Yawei Liu

107 papers receiving 2.5k citations

Peers

Yawei Liu
Stefano Tiziani United States
Min Young Lee South Korea
Sheng Li China
Stuart A. Rushworth United Kingdom
Xun Hu China
Yingli Wu China
Stefano Tiziani United States
Yawei Liu
Citations per year, relative to Yawei Liu Yawei Liu (= 1×) peers Stefano Tiziani

Countries citing papers authored by Yawei Liu

Since Specialization
Citations

This map shows the geographic impact of Yawei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawei Liu more than expected).

Fields of papers citing papers by Yawei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yawei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawei Liu. The network helps show where Yawei Liu may publish in the future.

Co-authorship network of co-authors of Yawei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yawei Liu. A scholar is included among the top collaborators of Yawei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yawei Liu. Yawei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Donghao, Yawei Liu, Lei Chen, et al.. (2025). Chemical Energy Lights Up Europium‐Based Ultra‐bright Afterglow for Bioanalysis Application. Angewandte Chemie. 137(15). 1 indexed citations
2.
Zhang, Yunxiao, Weizhao Li, Xian Zhang, et al.. (2025). TDP‐43/ALKBH5‐mediated m6A modification of CDC25A mRNA promotes glioblastoma growth by facilitating G1/S cell cycle transition. MedComm. 6(3). e70108–e70108. 1 indexed citations
3.
Li, Kaishu, Qihui Zhu, Zheng Yin, et al.. (2024). Imaging and Liquid Biopsy for Distinguishing True Progression From Pseudoprogression in Gliomas, Current Advances and Challenges. Academic Radiology. 31(8). 3366–3383. 5 indexed citations
4.
Chen, Hongjiang, et al.. (2023). Study on enhancement of hemoglobin antitoxic ability modified with chromium and ruthenium. International Journal of Biological Macromolecules. 242(Pt 2). 124756–124756.
5.
Liu, Yawei, Yun Huang, Xuan Shen, et al.. (2023). Long noncoding RNA <i>lnc_217</i> regulates hepatic lipid metabolism by modulating lipogenesis and fatty acid oxidation. Journal of Biomedical Research. 37(6). 448–448. 3 indexed citations
6.
Yang, Fan, Jingrong Lü, Huimin Zhao, et al.. (2023). Somalactams A–D: Anti‐inflammatory Macrolide Lactams with Unique Ring Systems from an Arctic Actinomycete Strain. Angewandte Chemie. 135(18). 1 indexed citations
7.
Yang, Fan, Jingrong Lü, Huimin Zhao, et al.. (2023). Somalactams A–D: Anti‐inflammatory Macrolide Lactams with Unique Ring Systems from an Arctic Actinomycete Strain. Angewandte Chemie International Edition. 62(18). e202218085–e202218085. 8 indexed citations
8.
Zhang, Yan, Kaiying Wang, Jianlong Li, et al.. (2023). Genomic epidemiological investigation of an outbreak of Serratia marcescens neurosurgical site infections associated with contaminated haircutting toolkits in a hospital barber shop. Journal of Hospital Infection. 142. 58–66. 1 indexed citations
9.
Li, Kaishu, Guanglong Huang, Ziyu Wang, et al.. (2022). IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(1). 166571–166571. 8 indexed citations
10.
Lin, Rui, Yimin Xu, Yunxiao Zhang, et al.. (2022). Recycling of SLC38A1 to the plasma membrane by DSCR3 promotes acquired temozolomide resistance in glioblastoma. Journal of Neuro-Oncology. 157(1). 15–26. 6 indexed citations
11.
Liu, Yawei, et al.. (2021). Status Quo and Research Trends of Neurosurgical Departments in China: Bibliometric and Scientometric Analyses. Journal of Medical Internet Research. 23(7). e25700–e25700. 2 indexed citations
12.
Zhang, Yunxiao, Tao Peng, Jinglin Guo, et al.. (2021). TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas. Cancer Cell International. 21(1). 148–148. 7 indexed citations
13.
Yang, Yang, Rui Wang, Lu Wang, et al.. (2021). Variety Discrimination Power: An Appraisal Index for Loci Combination Screening Applied to Plant Variety Discrimination. Frontiers in Plant Science. 12. 566796–566796. 9 indexed citations
14.
Guo, Jinglin, Guozhong Yi, Zhifeng Liu, et al.. (2019). Quantitative Proteomics Analysis Reveals Nuclear Perturbation in Human Glioma U87 Cells treated with Temozolomide. Cell Biochemistry and Function. 38(2). 185–194. 7 indexed citations
15.
Li, Yaomin, Yawei Liu, Jing Ren, et al.. (2018). miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma. Journal of Neuro-Oncology. 138(3). 499–508. 58 indexed citations
16.
Nie, Jing, Guanglong Huang, Shengze Deng, et al.. (2017). The purine receptor P2X7R regulates the release of pro-inflammatory cytokines in human craniopharyngioma. Endocrine Related Cancer. 24(6). 287–296. 18 indexed citations
17.
Zhang, Feifei, Yuhao Luo, Ziyun Shao, et al.. (2016). MicroRNA-187, a downstream effector of TGFβ pathway, suppresses Smad-mediated epithelial–mesenchymal transition in colorectal cancer. Cancer Letters. 373(2). 203–213. 64 indexed citations
18.
Wang, Hai, Yuntao Lu, Hezhen Li, et al.. (2016). Expression of dynein, cytoplasmic 2, heavy chain 1 (DHC2) associated with glioblastoma cell resistance to temozolomide. Scientific Reports. 6(1). 28948–28948. 17 indexed citations
19.
Wang, Hai, Xiang Peng, Yawei Liu, et al.. (2014). Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.. PubMed Central. 7(10). 6662–70. 62 indexed citations
20.
Liu, Zhifeng, Yawei Liu, Youqing Tang, et al.. (2010). Proteomic Analysis and Identification of Intestinal FBP as a Predictor of Gut Dysfunction During Heatstroke in Mice. Journal of Surgical Research. 173(2). 332–340. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026